AIGH Capital Management’s scPharmaceuticals SCPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,867,523	Closed	-$14.7M	–	53
2025 Q2	$14.7M	Sell	3,867,523 -228,844	-6%	-$710K	6.91%	3
2025 Q1	$10.8M	Sell	4,096,367 -78,000	-2%	-$254K	5.59%	6
2024 Q4	$14.8M	Buy	4,174,367 +50,000	+1%	+$192K	5.56%	8
2024 Q3	$18.8M	Buy	4,124,367 +620,002	+18%	+$3M	8.8%	4
2024 Q2	$15.2M	Buy	3,504,365 +115,206	+3%	+$506K	7.44%	6
2024 Q1	$17M	Buy	3,389,159 +282,364	+9%	+$1.58M	8.2%	3
2023 Q4	$19.5M	Buy	3,106,795 +899,786	+41%	+$5.15M	7.71%	2
2023 Q3	$15.7M	Buy	2,207,009 +155,204	+8%	+$1.22M	7.45%	2
2023 Q2	$20.9M	Sell	2,051,805 -23,992	-1%	-$250K	8.55%	2
2023 Q1	$18.8M	Sell	2,075,797 -474,437	-19%	-$3.48M	6.95%	2
2022 Q4	$18.3M	Buy	2,550,234 +1,793,171	+237%	+$11M	6.04%	5
2022 Q3	$4.94M	Sell	757,063 -589,661	-44%	-$3.15M	1.94%	18
2022 Q2	$6.49M	Sell	1,346,724 -50,000	-4%	-$247K	2.7%	16
2022 Q1	$7.93M	Buy	1,396,724 +23,600	+2%	+$116K	2.88%	16
2021 Q4	$6.89M	Buy	1,373,124 +139,003	+11%	+$765K	2.16%	14
2021 Q3	$8.21M	Buy	1,234,121 +591,967	+92%	+$3.54M	2.31%	17
2021 Q2	$3.92M	Sell	642,154 -212,988	-25%	-$1.28M	1.06%	29
2021 Q1	$5.69M	Buy	855,142 +217,820	+34%	+$1.49M	1.96%	24
2020 Q4	$3.37M	Buy	+637,322	New	+$4.99M	1.45%	22